Cam Gallagher
Founder at ZENTALIS PHARMACEUTICALS, INC.
Net worth: 10 M $ as of 30/03/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Johnson | M | 59 |
VelosBio, Inc.
 VelosBio, Inc. Miscellaneous Commercial ServicesCommercial Services VelosBio, Inc. operates as an biopharmaceutical company. It developes antibody-drug conjugates to treat hematological cancers and solid tumors. The company was founded in 2017 and is headquartered in San Diego, CA. | 7 years |
| Richard Vincent | M | 61 | 7 years | |
| Richard Rodgers | M | 57 | 4 years | |
| Kimberly Blackwell | M | 55 | 4 years | |
| Diana Hausman | M | 61 | 1 years | |
| Andreas Klostermann | M | - |
selectION, Inc.
 selectION, Inc. BiotechnologyHealth Technology selectION, Inc. provides a technology platform to develop peptide blockers for ion channels. The company was founded by Andreas Klostermann and is headquartered in San Diego, CA. | - |
| Enoch K. Kariuki | M | 42 |
VelosBio, Inc.
VelosBio, Inc. Miscellaneous Commercial ServicesCommercial Services VelosBio, Inc. operates as an biopharmaceutical company. It developes antibody-drug conjugates to treat hematological cancers and solid tumors. The company was founded in 2017 and is headquartered in San Diego, CA. | 4 years |
| Amy Rabourn | F | 44 | 5 years | |
| James Manuso | M | 75 |
OcuSub, Inc.
 OcuSub, Inc. BiotechnologyHealth Technology OcuSub, Inc. engages biotechnology services. It specializes in eye disorder treatment. The company was founded by Mina Patel Sooch, Alan R. Meyer, and William H. Pitlick in 2018 and is headquartered in Farmington Hills, MI. | 5 years |
| Bernhard Hoffmann | M | 68 | 6 years | |
| Andrea Paul | F | 43 | 2 years | |
| George Magrath | M | 40 | 1 years | |
| Sean Ainsworth | M | 56 | 6 years | |
| Erik Sims | M | - | 3 years | |
| Karan Takhar | M | 32 | 7 years | |
| Xin Nakanishi | M | 62 | 6 years | |
| Peter Nunez | M | - |
University of San Diego
| 30 years |
| Jan Skvarka | M | 57 | 2 years | |
| Jay Pepose | M | 69 | 3 years | |
| Meena Rao | M | - | 7 years | |
| Mike A. Royal | M | 70 | 10 years | |
| Susan Benton | F | 59 | 4 years | |
| Charles Theuer | M | 60 | 6 years | |
| William LaRue | M | 73 | 7 years | |
| Jaisim Shah | M | 63 | 11 years | |
| Antonius P. Schuh | M | 59 |
selectION, Inc.
selectION, Inc. BiotechnologyHealth Technology selectION, Inc. provides a technology platform to develop peptide blockers for ion channels. The company was founded by Andreas Klostermann and is headquartered in San Diego, CA. | - |
| Mark Wiggins | M | 68 |
selectION, Inc.
selectION, Inc. BiotechnologyHealth Technology selectION, Inc. provides a technology platform to develop peptide blockers for ion channels. The company was founded by Andreas Klostermann and is headquartered in San Diego, CA. | - |
| Mark Lackner | M | 56 | 2 years | |
| Ronil Patel | M | - | 3 years | |
| Alexandra Roy | F | - | - | |
| Drey Coleman | F | - | - | |
| Julia Deutsch | F | - | - | |
| Barbara Withers | F | - | - | |
| Donald Scifres | M | - |
selectION, Inc.
selectION, Inc. BiotechnologyHealth Technology selectION, Inc. provides a technology platform to develop peptide blockers for ion channels. The company was founded by Andreas Klostermann and is headquartered in San Diego, CA. | - |
| Dimitris Voliotis | M | 61 | 4 years | |
| Ziad Henry Moukheiber | M | - |
RetroSense Therapeutics LLC
 RetroSense Therapeutics LLC Medical SpecialtiesHealth Technology RetroSense Therapeutics LLC provides biotechnology services. It offers gene therapies to restore vision in patients suffering from blindness due to retinitis pigmentosa and advanced dry age-related macular degeneration. The company was founded by Sean Ainsworth in 2009 and is headquartered in Ann Arbor, MI. | 9 years |
| Mitchell Brigell | M | - | - | |
| Alice B. Hayes | M | 86 |
University of San Diego
| 29 years |
| Kyle Rasbach | M | - | - | |
| Nirav Jhaveri | M | 46 | - | |
| Carey Ng | M | 45 |
Mesa Verde Ventures LLC
 Mesa Verde Ventures LLC Investment ManagersFinance Mesa Verde Ventures LLC (Mesa Verde Ventures) is a venture capital firm founded in 2006. The firm is headquartered in San Diego, California. | 16 years |
| Tiba Aynechi | M | 48 |
Ray Therapeutics, Inc.
 Ray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Ray Therapeutics, Inc. is an American company that is developing a lead candidate, RTX-015, to treat retinitis pigmentosa, a degenerative retinal disease. Ray Therapeutics is based in an undisclosed location. The company's mission is to restore vision for people with retinal degeneration using optogenetics gene therapies. Ray Therapeutics is pursuing multiple drug development programs for a range of degenerative retinal diseases, focusing on preserving and restoring vision in patients using the ground-breaking science of optogenetics. The company was founded by Paul Bresge and Sean Ainsworth, with Paul Bresge serving as CEO since incorporation. | 1 years |
| David Mallery | M | - |
Mesa Verde Ventures LLC
Mesa Verde Ventures LLC Investment ManagersFinance Mesa Verde Ventures LLC (Mesa Verde Ventures) is a venture capital firm founded in 2006. The firm is headquartered in San Diego, California. | - |
| Joseph Schachle | M | 59 | 1 years | |
| Kimberly Freeman | F | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mina Sooch | F | 56 |
OcuSub, Inc.
OcuSub, Inc. BiotechnologyHealth Technology OcuSub, Inc. engages biotechnology services. It specializes in eye disorder treatment. The company was founded by Mina Patel Sooch, Alan R. Meyer, and William H. Pitlick in 2018 and is headquartered in Farmington Hills, MI. | 5 years |
| Mark W. Durand | M | 64 | 1 years | |
| Kevin Bunker | M | 52 | 9 years | |
| Douglas J. Langston | M | 63 | 3 years | |
| Melissa Epperly | F | 46 | 5 years | |
| Tony Sun | M | 52 | 8 years | |
| Dmitry Kuzmin | M | - |
RetroSense Therapeutics LLC
RetroSense Therapeutics LLC Medical SpecialtiesHealth Technology RetroSense Therapeutics LLC provides biotechnology services. It offers gene therapies to restore vision in patients suffering from blindness due to retinitis pigmentosa and advanced dry age-related macular degeneration. The company was founded by Sean Ainsworth in 2009 and is headquartered in Ann Arbor, MI. | - |
| David R. Webb | M | 79 | 2 years | |
| Glenn L. Halpryn | M | 63 | 4 years | |
| Christopher Chai | M | 58 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 8 years |
| Alexis Pinto | F | 57 | 2 years | |
| Curtis Lockshin | M | 64 | 4 years | |
| Adam Simpson | M | 49 |
Verus Pharmaceuticals, Inc.
 Verus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Verus Pharmaceuticals, Inc. was provided pediatric-oriented pharmaceutical products. The company was founded by David A. Socks, James Carroll Blair, Robert W. Keith, Cam L. Garner and David F. Hale in 2002 and was headquartered in San Diego, CA. | 3 years |
| Langdon L. Miller | M | 70 |
VelosBio, Inc.
VelosBio, Inc. Miscellaneous Commercial ServicesCommercial Services VelosBio, Inc. operates as an biopharmaceutical company. It developes antibody-drug conjugates to treat hematological cancers and solid tumors. The company was founded in 2017 and is headquartered in San Diego, CA. | 2 years |
| Vuong Trieu | M | 59 | 1 years | |
| William S. Marth | M | 69 | - | |
| Cam Garner | M | 75 |
Dura Pharmaceuticals, Inc.
 Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Dura Pharmaceuticals, Inc. markets and sells prescription products that treat infectious and respiratory diseases. Dura focuses on products and transactions that leverage its sales and marketing organization. Dura also intends, through the use of collaborative relationships, to develop the Spiros® motorized blisterdisk and Spiros® S2 pulmonary drug delivery systems for the local and systemic delivery of a wide range of medications. It is located in San Diego, CA. | 11 years |
| William Vaughan | M | - |
The Ohio University
 The Ohio University Other Consumer ServicesConsumer Services Central Hockey League operates a professional minor league hockey teams playing in small to medium-sized markets primarily in central and southwestern US states. The league, which was started in 1992, is managed and operated by WPHL, a subsidiary of Global Entertainment Corporation. | 11 years |
| M. Scott Salka | M | 62 | 2 years | |
| Erle T. Mast | M | 61 |
Dura Pharmaceuticals, Inc.
Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Dura Pharmaceuticals, Inc. markets and sells prescription products that treat infectious and respiratory diseases. Dura focuses on products and transactions that leverage its sales and marketing organization. Dura also intends, through the use of collaborative relationships, to develop the Spiros® motorized blisterdisk and Spiros® S2 pulmonary drug delivery systems for the local and systemic delivery of a wide range of medications. It is located in San Diego, CA.
Verus Pharmaceuticals, Inc.
Verus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Verus Pharmaceuticals, Inc. was provided pediatric-oriented pharmaceutical products. The company was founded by David A. Socks, James Carroll Blair, Robert W. Keith, Cam L. Garner and David F. Hale in 2002 and was headquartered in San Diego, CA. | 6 years |
| Todd W. Schmidt | M | 81 |
Dura Pharmaceuticals, Inc.
Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Dura Pharmaceuticals, Inc. markets and sells prescription products that treat infectious and respiratory diseases. Dura focuses on products and transactions that leverage its sales and marketing organization. Dura also intends, through the use of collaborative relationships, to develop the Spiros® motorized blisterdisk and Spiros® S2 pulmonary drug delivery systems for the local and systemic delivery of a wide range of medications. It is located in San Diego, CA. | 19 years |
| Douglas O. Ebersole | M | 68 | 2 years | |
| Ernst-Günter Afting | M | 80 | 2 years | |
| Jane Hsaio | M | 77 | 3 years | |
| Kenneth Lee | M | 76 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 7 years |
| Alan R. Meyer | M | - | 3 years | |
| Tricia Borga Suvari | F | 63 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 11 years |
| Brad Zellar | M | - |
The Ohio University
The Ohio University Other Consumer ServicesConsumer Services Central Hockey League operates a professional minor league hockey teams playing in small to medium-sized markets primarily in central and southwestern US states. The league, which was started in 1992, is managed and operated by WPHL, a subsidiary of Global Entertainment Corporation. | 14 years |
| Kevin Barrett | M | - |
University of San Diego
| 4 years |
| Angelique Aryanto | F | 53 |
University of San Diego
| 2 years |
| Karina Vollmer | F | - |
University of San Diego
| 4 years |
| James Brennan | M | - |
University of San Diego
| 4 years |
| Patricia Riley | F | - |
University of San Diego
| 1 years |
| Christian Dominik Frey | M | - |
University of San Diego
| 2 years |
| Nicole Dragoo | F | - |
University of San Diego
| 4 years |
| Celeste Burgoyne | F | 50 |
University of San Diego
| 4 years |
| Charles A. Villano | M | - |
University of San Diego
| 2 years |
| Linda Brewton | F | - |
University of San Diego
| 3 years |
| Andrew O'Donnell | M | - |
University of San Diego
| 4 years |
| Scott J. Menghini | M | - |
University of San Diego
| 3 years |
| Steven M. Freeland | M | - |
University of San Diego
| 3 years |
| Jamie Hewitt Moraga | F | - |
University of San Diego
| 4 years |
| Matt Weber | M | - |
University of San Diego
| 4 years |
| Amelia Bharata | F | 50 |
University of San Diego
| - |
| Alex P. Rohr | M | - |
University of San Diego
| 4 years |
| Teri O'Brien | F | - |
University of San Diego
| 3 years |
| Michael Murni Gunawan | M | 62 |
University of San Diego
| 2 years |
| Andy B. Serwin | M | - |
University of San Diego
| 3 years |
| David Stern | M | - |
University of San Diego
| 3 years |
| Ryan A. Murr | M | - |
University of San Diego
| 3 years |
| Michael Lavin | M | 51 |
University of San Diego
| 3 years |
| Ryan D. Johnson | M | - |
University of San Diego
| 4 years |
| Mark Draper Flint | M | - |
University of San Diego
| 5 years |
| Jose Delgado | M | - |
University of San Diego
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 99 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Cam Gallagher
- Personal Network
